Mirna21 Expression in the Breast Cancer Tumor Tissue is Independent of Neoadjuvant Chemotherapy
Authors:
- Alexandre Cesar Vieira SalesASAlexandre Cesar Vieira Sales
- Isaura Isabelle Fonseca Gomes da SilvaISIsaura Isabelle Fonseca Gomes da Silva
- Leandro L CoutinhoLCLeandro L Coutinho
- Renata Bac ReisRRRenata Bac Reis
- Angela CastoldiACAngela Castoldi
- Danyelly Bg MartinsDMDanyelly Bg Martins
- José Luiz Lima-FilhoJLJosé Luiz Lima-Filho
- Fabricio Oliveira SoutoFSFabricio Oliveira Souto
Open Access
- 1 October 2020
- journal article
- research article
- Published by Taylor & Francis in Breast Cancer: Targets and Therapy
- Vol. ume 12, 141-151
Abstract
Introduction: MicroRNA-21 (miRNA-21) has been described as one of the most significantly upregulated miRNAs in human breast cancer. However, limited knowledge exists on miRNA-21 expression in breast cancer tissue after neoadjuvant chemotherapy (NAC). Purpose: The aim of this study was to assess miRNA-21 expression in the tumor tissues of Brazilian patients with breast cancer who underwent NAC and its correlation with clinicopathological variables. Patients and Methods: Utilizing qRT-PCR, miRNA-21 expression in tumor tissue was measured in a cohort of female patients with breast cancer who underwent NAC. The correlation of miRNA-21 expression with breast cancer molecular subtypes and other clinicopathological variables was also assessed. Results: A total of 55 patients were included in the study, and 28 (50.9%) underwent NAC. miRNA-21 was upregulated in patients with breast cancer, regardless of previous exposure to chemotherapy, molecular subtypes, tumor-node-metastasis (TNM) staging and lymph node status of the axilla. miRNA-21 expression did not differ between patients with breast cancer who achieved a pathologic complete response after NAC and healthy controls. Conclusion: miRNA-21 was upregulated in the tumor tissue of Brazilian patients with breast cancer regardless of NAC treatment, which reinforces its role as an “oncomiR” and a potential biomarker.Keywords
This publication has 39 references indexed in Scilit:
- Clinical Translatability of “Identified” Circulating miRNAs for Diagnosing Breast Cancer: Overview and UpdateCancers, 2019
- Relative and Absolute Expression Analysis of MicroRNAs Associated with Luminal A Breast Cancer– A ComparisonPathology and Oncology Research, 2019
- Eighth Edition of the AJCC Cancer Staging Manual: Breast CancerAnnals of Surgical Oncology, 2018
- Risk Factors for Breast Cancer for Women Aged 40 to 49 YearsAnnals of Internal Medicine, 2012
- Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast CancerClinical Chemistry, 2011
- Emerging role of microRNAs in diagnosis and treatment of various diseases including ovarian cancerJournal of Ovarian Research, 2009
- MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosisRNA, 2008
- Altered MicroRNA Expression Confined to Specific Epithelial Cell Subpopulations in Breast CancerCancer Research, 2007
- Expression profiling identifies microRNA signature in pancreatic cancerInternational Journal of Cancer, 2006
- miR-21-mediated tumor growthOncogene, 2006